Physician profile
Melissa Lawrence
NPI 1316169220
$10,361.14
in general payments reported to CMS, 2019-2025
23 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,891 · 2020: $1,223 · 2021: $1,286 · 2022: $318 · 2023: $425 · 2024: $115 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,911.82 | 2019-2020 | |
| Cgg Medical INC | $1,923.77 | 2020-2022 | |
| Djo, LLC | $282.79 | 2019-2024 | Cmf |
| Organogenesis INC. | $270.21 | 2020-2023 | Puraply |
| Stryker Corporation | $167.37 | 2023-2024 | Variax, Mako, Motionsense Digital Goniometer |
| Pacira Therapeutics, INC. | $107.65 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $106.40 | 2020-2023 | Persona |
| Horizon Therapeutics Plc | $96.82 | 2019-2023 | Tepezza |
| Depuy Synthes Sales INC. | $76.34 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $68.75 | 2022-2025 | Zilretta, Exparel, Iovera |
| Vertex Pharmaceuticals Incorporated | $54.18 | 2025 | |
| Conetic Solutions, INC. | $40.24 | 2023-2024 | |
| Si-Bone, INC. | $34.14 | 2019-2020 | |
| Orthofix Medical, INC. | $30.89 | 2025 | Accelstim, Physio-Stim |
| Endo Pharmaceuticals INC. | $30.88 | 2022-2023 | Xiaflex |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $26.11 | 2022 | |
| Convatec INC. | $22.74 | 2023 | |
| Avanos Medical | $22.52 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $21.82 | 2022 | |
| Amgen INC. | $20.04 | 2019 | |
| Spine Wave, INC. | $16.27 | 2019 | |
| Orthogenrx INC. | $14.95 | 2021 | |
| Baudax Bio INC. | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.